{
    "Trade/Device Name(s)": [
        "Healthpro Blood Glucose Monitoring System",
        "Healthpro Blood Glucose Test System"
    ],
    "Submitter Information": "Infopia Co., Ltd",
    "510(k) Number": "K113192",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091157"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX",
        "LFR"
    ],
    "Summary Letter Date": "June 6, 2012",
    "Summary Letter Received Date": "June 7, 2012",
    "Submission Date": "July 9, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Healthpro meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strips",
        "Control Solution",
        "Meter",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Healthpro Blood Glucose Monitoring System measuring glucose in capillary whole blood using electrochemical detection",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from multiple body sites for self-testing by single patients with diabetes at home; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}